NRAS rs2273267 A > T polymorphism reduces neuroblastoma risk in Chinese children.

NRAS rs2273267 A>T polymorphism reduces neuroblastoma risk in Chinese children. Gene. 2019 Nov 21;:144262 Authors: Li S, Zhuo Z, Chang X, Ma Y, Zhou H, Zhang J, Cheng J, He J, Li Y Abstract Neuroblastoma is an extracranial solid tumor that mainly occurs in childhood. Mutations of NRAS gene have been described in several cancers. However, whether NRAS gene polymorphisms can predict the risk of neuroblastoma have not been investigated. We hypothesized that variations of NRAS gene contribute to neuroblastoma predisposition. Therefore, we conducted a multi-center case-control study using 263 cases and 715 controls to examine the association of NRAS gene rs2273267 A>T polymorphism and neuroblastoma risk. We calculated odds ratios (ORs) and corresponding 95% confidence intervals (CIs) to assess the strength of the associations. Relative to those with AA genotype, subjects with AT/TT genotype had reduced neuroblastoma risk (adjusted OR=0.72, 95% CI=0.54-0.96, P=0.024). Stratified analysis revealed that rs2273267 AT/TT carriers were less likely to develop neuroblastoma for patients with tumor originating from the adrenal gland (adjusted OR=0.67, 95% CI=0.45-0.99, P=0.047) and clinical stages III+IV (adjusted OR=0.57, 95% CI=0.36-0.90, P=0.015). Our findings underline the likely importance of NRAS gene rs2273267 A>T in the risk of neuroblastoma. Further independent case-control studies with functional analysis are needed to verify th...
Source: Gene - Category: Genetics & Stem Cells Authors: Tags: Gene Source Type: research